Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations.

PubWeight™: 1.73‹?› | Rank: Top 3%

🔗 View Article (PMID 15372542)

Published in Muscle Nerve on October 01, 2004

Authors

A Muchir1, J Medioni, M Laluc, C Massart, T Arimura, A J van der Kooi, I Desguerre, M Mayer, X Ferrer, S Briault, M Hirano, H J Worman, A Mallet, M Wehnert, K Schwartz, G Bonne

Author Affiliations

1: INSERM U582, Institut de Myologie, GH Pitié-Salpêtrière, Bâtiment Babinski, 47 boulevard de l'Hôpital, Paris 75013, France.

Articles citing this

"Laminopathies": a wide spectrum of human diseases. Exp Cell Res (2007) 3.46

Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. Proc Natl Acad Sci U S A (2005) 3.30

Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. Proc Natl Acad Sci U S A (2005) 2.85

Nuclear mechanics during cell migration. Curr Opin Cell Biol (2010) 2.32

Diseases of the nuclear envelope. Cold Spring Harb Perspect Biol (2010) 2.12

Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy. J Invest Dermatol (2005) 2.06

Dysfunctional connections between the nucleus and the actin and microtubule networks in laminopathic models. Biophys J (2008) 1.92

Deficiencies in lamin B1 and lamin B2 cause neurodevelopmental defects and distinct nuclear shape abnormalities in neurons. Mol Biol Cell (2011) 1.86

The posttranslational processing of prelamin A and disease. Annu Rev Genomics Hum Genet (2009) 1.81

Lamin A variants that cause striated muscle disease are defective in anchoring transmembrane actin-associated nuclear lines for nuclear movement. Proc Natl Acad Sci U S A (2010) 1.61

Direct synthesis of lamin A, bypassing prelamin a processing, causes misshapen nuclei in fibroblasts but no detectable pathology in mice. J Biol Chem (2010) 1.24

Myopathic lamin mutations impair nuclear stability in cells and tissue and disrupt nucleo-cytoskeletal coupling. Hum Mol Genet (2013) 1.17

Muscular dystrophy-associated SUN1 and SUN2 variants disrupt nuclear-cytoskeletal connections and myonuclear organization. PLoS Genet (2014) 1.13

Dependence of diffusional mobility of integral inner nuclear membrane proteins on A-type lamins. Biochemistry (2006) 1.12

Genetics of inherited cardiomyopathy. Eur Heart J (2011) 1.11

In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J Med Genet (2005) 1.07

The role of Drosophila Lamin C in muscle function and gene expression. Development (2010) 1.05

Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption. Basic Res Cardiol (2010) 1.03

Mechanical model of blebbing in nuclear lamin meshworks. Proc Natl Acad Sci U S A (2013) 1.00

Structural organization of nuclear lamins A, C, B1, and B2 revealed by superresolution microscopy. Mol Biol Cell (2015) 0.98

LINCing lamin B2 to neuronal migration: growing evidence for cell-specific roles of B-type lamins. Nucleus (2011) 0.98

The functions of the nuclear envelope in mediating the molecular crosstalk between the nucleus and the cytoplasm. Curr Opin Cell Biol (2011) 0.98

BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. Mol Cell Proteomics (2015) 0.95

Proteasome-mediated degradation of integral inner nuclear membrane protein emerin in fibroblasts lacking A-type lamins. Biochem Biophys Res Commun (2006) 0.91

Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan. Acta Myol (2007) 0.89

Soft substrates normalize nuclear morphology and prevent nuclear rupture in fibroblasts from a laminopathy patient with compound heterozygous LMNA mutations. Nucleus (2013) 0.88

Lamina-associated polypeptide (LAP)2α and nucleoplasmic lamins in adult stem cell regulation and disease. Semin Cell Dev Biol (2013) 0.88

Nuclear mechanics in cancer. Adv Exp Med Biol (2014) 0.88

Monoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482W. PLoS One (2010) 0.86

Targeting protein prenylation in progeria. Sci Transl Med (2013) 0.85

Cytoplasmic localization of PML particles in laminopathies. Histochem Cell Biol (2012) 0.85

Nuclear envelope rupture is induced by actin-based nucleus confinement. J Cell Biol (2016) 0.85

Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutation. Eur J Hum Genet (2011) 0.83

The cell biology of aging. Mol Biol Cell (2015) 0.82

A laminopathic mutation disrupting lamin filament assembly causes disease-like phenotypes in Caenorhabditis elegans. Mol Biol Cell (2011) 0.81

Modeling nuclear blebs in a nucleoskeleton of independent filament networks. Cell Mol Bioeng (2011) 0.81

Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. Hum Mol Genet (2015) 0.80

LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies. BMC Med Genet (2013) 0.79

Lamin A/C mutants disturb sumo1 localization and sumoylation in vitro and in vivo. PLoS One (2012) 0.79

Structural protein 4.1R is integrally involved in nuclear envelope protein localization, centrosome-nucleus association and transcriptional signaling. J Cell Sci (2011) 0.79

Altering lamina assembly reveals lamina-dependent and -independent functions for A-type lamins. J Cell Sci (2015) 0.78

AFM single-cell force spectroscopy links altered nuclear and cytoskeletal mechanics to defective cell adhesion in cardiac myocytes with a nuclear lamin mutation. Nucleus (2015) 0.77

Gene-rich chromosomal regions are preferentially localized in the lamin B deficient nuclear blebs of atypical progeria cells. Nucleus (2015) 0.77

Skin deep: what can the study of dermal fibroblasts teach us about dilated cardiomyopathy? J Mol Cell Cardiol (2009) 0.77

Novel insights into the disease etiology of laminopathies. Rare Dis (2013) 0.75

A Novel Lamin A Mutant Responsible for Congenital Muscular Dystrophy Causes Distinct Abnormalities of the Cell Nucleus. PLoS One (2017) 0.75

Hallermann-Streiff Syndrome: No Evidence for a Link to Laminopathies. Mol Syndromol (2011) 0.75

The effect of the lamin A and its mutants on nuclear structure, cell proliferation, protein stability, and mobility in embryonic cells. Chromosoma (2016) 0.75

Articles by these authors

Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47

Nuclear membrane dynamics and reassembly in living cells: targeting of an inner nuclear membrane protein in interphase and mitosis. J Cell Biol (1997) 6.57

Condensins, chromosome condensation protein complexes containing XCAP-C, XCAP-E and a Xenopus homolog of the Drosophila Barren protein. Cell (1997) 5.86

Identification of Xenopus SMC protein complexes required for sister chromatid cohesion. Genes Dev (1998) 5.78

Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature (2000) 5.71

QUANTITATIVE CHEMICAL STUDIES ON COMPLEMENT OR ALEXIN : IV. ADDITION OF HUMAN COMPLEMENT TO SPECIFIC PRECIPITATES. J Exp Med (1942) 5.34

Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet (1999) 5.04

Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature (1993) 4.87

The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet (2001) 4.54

Synthesis and cytotoxicity of gossypol related compounds. Eur J Med Chem (2000) 4.25

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet (1999) 4.20

Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology (2006) 4.11

Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science (1999) 4.05

Phosphorylation and activation of 13S condensin by Cdc2 in vitro. Science (1998) 3.89

A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet (1997) 3.79

Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem (1993) 3.70

Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology (2000) 3.46

Exaggerated anesthetic requirements in the preferentially anesthetized brain. Anesthesiology (1993) 3.37

Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev (2006) 3.30

A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet (2004) 3.24

Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet (1995) 3.05

Interaction between an integral protein of the nuclear envelope inner membrane and human chromodomain proteins homologous to Drosophila HP1. J Biol Chem (1996) 2.90

Myosin isoenzyme redistribution in chronic heart overload. Nature (1979) 2.89

Elevated serum aminotransferase activity as an early manifestation of gluten-sensitive enteropathy. J Pediatr (1993) 2.88

Three myosin heavy-chain isozymes appear sequentially in rat muscle development. Nature (1981) 2.88

Localization and phosphorylation of HP1 proteins during the cell cycle in mammalian cells. Chromosoma (1999) 2.79

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest (1999) 2.77

The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol (1998) 2.72

Myoblast transplantation for heart failure. Lancet (2001) 2.71

A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer (1979) 2.67

Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model. Drug Metab Rev (1984) 2.65

Morphological structure of the vocal cord as a vibrator and its variations. Folia Phoniatr (Basel) (1974) 2.62

Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. Am J Med (1984) 2.60

Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet (1999) 2.59

Domain-specific interactions of human HP1-type chromodomain proteins and inner nuclear membrane protein LBR. J Biol Chem (1997) 2.58

Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology (2008) 2.57

A QUANTITATIVE THEORY OF THE PRECIPITIN REACTION : VII. THE EGG ALBUMIN-ANTIBODY REACTION IN ANTISERA FROM THE RABBIT AND HORSE. J Exp Med (1940) 2.53

Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int (2006) 2.52

Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet (2000) 2.52

Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet (1995) 2.52

MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol (1992) 2.48

Relation between sexual practices and T-cell subsets in homosexually active men. Lancet (1983) 2.46

Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest (1987) 2.37

Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature (1998) 2.36

Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc Natl Acad Sci U S A (1984) 2.26

Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res (1997) 2.25

Signals and structural features involved in integral membrane protein targeting to the inner nuclear membrane. J Cell Biol (1995) 2.25

Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J (1999) 2.24

Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. Eur Heart J (1998) 2.20

Myosin isoenzyme changes in several models of rat cardiac hypertrophy. Circ Res (1981) 2.20

Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc Natl Acad Sci U S A (2000) 2.19

Cervical dystonia: clinical findings and associated movement disorders. Neurology (1991) 2.16

Sequential sorafenib and sunitinib for renal cell carcinoma. J Urol (2009) 2.12

MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet (2001) 2.12

Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib. Ann Oncol (2010) 2.11

Primary structure analysis and lamin B and DNA binding of human LBR, an integral protein of the nuclear envelope inner membrane. J Biol Chem (1994) 2.11

Blindness after reduction of facial fractures. Plast Reconstr Surg (1998) 2.08

Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry (2005) 2.08

Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy. J Cell Sci (2001) 2.05

Transmission at a central inhibitory synapse. II. Quantal description of release, with a physical correlate for binomial n. J Neurophysiol (1982) 2.04

Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation (1998) 2.04

Both emerin and lamin C depend on lamin A for localization at the nuclear envelope. J Cell Sci (2001) 2.01

Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature (1993) 2.00

Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology (2006) 1.98

'Outbreak' of optic and peripheral neuropathy in Cuba? JAMA (1993) 1.97

Duchenne muscular dystrophy (DMD) in a female with an X/autosome translocation: further evidence that the DMD locus is at Xp21. Am J Hum Genet (1981) 1.97

1st International consensus guidelines for advanced breast cancer (ABC 1). Breast (2012) 1.96

MAN1, an inner nuclear membrane protein that shares the LEM domain with lamina-associated polypeptide 2 and emerin. J Biol Chem (2000) 1.95

QUANTITATIVE CHEMICAL STUDIES ON COMPLEMENT OR ALEXIN : III. UPTAKE OF COMPLEMENT NITROGEN UNDER VARYING EXPERIMENTAL CONDITIONS. J Exp Med (1941) 1.94

Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest (1990) 1.94

X-linked mental retardation: a study of 7 families. Am J Med Genet (1980) 1.93

Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology (1992) 1.93

Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res (1998) 1.92

The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity. Mol Cell Biol (1994) 1.91

Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology (2005) 1.90

Alpha-skeletal muscle actin mRNA's accumulate in hypertrophied adult rat hearts. Circ Res (1986) 1.90

Analyis of met-form haemoglobins in human erythrocytes of normal adults and of a patient with hereditary methaemoglobinaemia due to deficiency of NADH-cytochrome b5 reductase. Biochem J (1979) 1.88

Intracellular trafficking of emerin, the Emery-Dreifuss muscular dystrophy protein. J Cell Sci (1999) 1.85

Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol (2000) 1.84

Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet (2000) 1.84

Direct observation of specific messenger RNA in a single living cell under a fluorescence microscope. Biophys J (2000) 1.83

Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology (2004) 1.83

Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol (2000) 1.82

Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology (2005) 1.80

Contractile protein isozymes in muscle development: identification of an embryonic form of myosin heavy chain. Proc Natl Acad Sci U S A (1979) 1.80

Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes. Eur Heart J (1998) 1.79

Myosin isoenzymic distribution correlates with speed of myocardial contraction. J Mol Cell Cardiol (1981) 1.79

Mutations in PHF8 are associated with X linked mental retardation and cleft lip/cleft palate. J Med Genet (2005) 1.78